Core Viewpoint - The company Beiyinmei is currently involved in a significant legal dispute with Heilongjiang Fengyou regarding patent contract issues, with both parties filing lawsuits against each other, which may impact the company's financial performance and control structure in the future [1][3]. Group 1: Legal Dispute Details - Beiyinmei has filed a lawsuit against Heilongjiang Fengyou for patent contract disputes, and the Hangzhou Intermediate People's Court has accepted the case [1]. - Heilongjiang Fengyou has counterclaimed, seeking compensation of 77.2539 million yuan from Beiyinmei for economic losses due to alleged breaches of contract [2]. - The agreements in question were signed in November 2021 and January 2022, involving exclusive licensing and joint research cooperation [1]. Group 2: Claims by Heilongjiang Fengyou - Heilongjiang Fengyou asserts that it has fulfilled all core obligations under the contract, including delivering necessary patent application documents and ensuring the exclusivity of the license [2]. - The company claims it has not engaged with any third parties in the relevant market, thereby maintaining Beiyinmei's exclusive position in the mainland China market [2]. - Heilongjiang Fengyou has made significant upfront investments to support the development of patented products, which it claims have resulted in substantial economic losses [2]. Group 3: Financial and Control Implications - Beiyinmei acknowledges the uncertainty regarding the impact of the ongoing litigation on its current and future profits, indicating potential accounting adjustments may be necessary [3]. - The company's major shareholder, Zhejiang Xiaobei Demei Holdings, is undergoing a public recruitment process for investors to facilitate debt repayment and corporate restructuring, which could lead to changes in control [3]. - As of the announcement date, the major shareholder holds 133 million shares (12.28% of total shares), with 98.85% of these shares pledged or under judicial freeze [3].

Core Viewpoint - The company, Beiyinmei Co., Ltd., is currently involved in two lawsuits regarding patent contract disputes, with significant financial implications pending court decisions [8][10]. Group 1: Main Lawsuit Details - The main lawsuit involves Beiyinmei suing Heilongjiang Fengyou for a patent contract dispute, with the case accepted by the Hangzhou Intermediate People's Court and yet to be heard [8][9]. - The amount claimed in the main lawsuit is 56,852,397.26 yuan, including interest losses calculated until November 20, 2025 [3]. - The impact of this lawsuit on the company's current and future profits is uncertain due to the pending court hearing [3][13]. Group 2: Counterclaim Details - Heilongjiang Fengyou has filed a counterclaim against Beiyinmei, also accepted by the Hangzhou Intermediate People's Court and yet to be heard [9][10]. - The counterclaim seeks compensation of 77,253,939.28 yuan for economic losses allegedly caused by Beiyinmei's breach of contract [6][11]. - The counterclaim asserts that Heilongjiang Fengyou fulfilled its contractual obligations, while Beiyinmei failed to meet its primary obligations as the contract's leading party [10][11]. Group 3: Other Legal Matters - As of the announcement date, the company and its subsidiaries are involved in minor lawsuits that do not meet the disclosure standards for significant litigation as per the Shenzhen Stock Exchange regulations [12].

Core Viewpoint - The company is involved in a patent contract dispute with Heilongjiang Fengyou, with a claim amounting to 56.8524 million yuan, which has been accepted by the Hangzhou Intermediate Court but has not yet gone to trial [1] Group 1 - The company has filed a lawsuit against Heilongjiang Fengyou regarding a patent contract dispute [1] - The amount in dispute from the company's lawsuit is 56.8524 million yuan [1] - Heilongjiang Fengyou has counterclaimed against the company, seeking compensation for economic losses amounting to 77.2539 million yuan and reimbursement of counterclaim costs [1] Group 2 - The counterclaim from Heilongjiang Fengyou has also been accepted by the court and is pending trial [1] - Due to the ongoing nature of the legal proceedings, the company is currently unable to estimate the impact on its profits [1] - The company will monitor the situation closely and provide timely updates on any developments [1]

Group 1 - The company is involved in a patent contract dispute as the plaintiff, with the amount in question being 56.8524 million yuan [1] - The company is also a defendant in a counterclaim case, with the amount involved being 77.2539 million yuan [1] - Both cases have been accepted but have not yet gone to trial [1]

证券代码：002570 证券简称：贝因美 公告编号：2026-016 贝因美股份有限公司 关于公司重大诉讼事项的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 特别提示： （一）本诉案件： 1、案件所处的诉讼阶段：浙江省杭州市中级人民法院已经受理，尚未开庭 审理。 1、案件所处的诉讼阶段：浙江省杭州市中级人民法院已经受理，尚未开庭 审理。 2、公司所处的当事人地位：反诉被告。 3、涉案金额：反诉请求金额为 77,253,939.28 元。 4、对上市公司损益产生的影响：本次诉讼由于尚未开庭审理，后续判决结 果尚存在不确定性，暂时无法预计其对公司本期利润或期后利润的影响。 敬请广大投资者谨慎决策，注意投资风险。 2、公司所处的当事人地位：原告。 3、涉案金额：本诉请求金额为 56,852,397.26 元（其中，利息损失暂算至 2025 年 11 月 20 日）。 4、对上市公司损益产生的影响：本次诉讼由于尚未开庭审理，后续判决结 果尚存在不确定性，暂时无法预计其对公司本期利润或期后利润的影响。 （二）反诉案件： 反诉被告：贝因美股份有限公司 2、诉讼 ...

Core Viewpoint - The dairy industry in the A-share market has shown strong resilience with nearly 90% of the 19 major dairy companies experiencing stock price increases, reflecting a robust recovery in consumer demand [1] Group 1: Performance Overview - 17 out of 19 major dairy companies in the A-share market recorded stock price increases, indicating a significant upward trend in the sector [1] - Leading the gains are regional boutique dairy companies and segment leaders, with Zhuangyuan Pasture (002910) achieving a remarkable 63.46% increase, followed by Knight Dairy (920786) at 50.83% and Beingmate (002570) at 48.65% [1][2] Group 2: Industry Leaders - Industry giants Yili (600887) and Mengniu (02319.HK) continue to serve as the "industry ballast," maintaining stable performance amidst a complex market environment [2] - Yili has shown positive growth and remains a preferred choice for investors due to its solid dividend capacity and fundamental stability, while Mengniu has strengthened its global position through ongoing brand upgrades and international expansion [2] Group 3: Divergence in Performance - Despite the overall positive trend, there are exceptions with Bright Dairy (600597) and Jiahe Foods (605300) experiencing declines of 1.54% and 8.79% respectively, attributed to intense competition and cost pressures [3] - Upstream companies like Modern Dairy (01117.HK) are facing challenges due to prolonged low raw milk prices, which have severely compressed profit margins [3] - The dairy sector is transitioning from "volume growth" to "quality transformation," with leading companies and regional dark horses contributing to the industry's prosperity, despite some facing short-term challenges [3]

Recent Events - The restructuring plan of the controlling shareholder, Zhejiang Xiaobei Demei Holdings Co., Ltd., was approved by the creditors' meeting on January 30, 2026, and the management is publicly recruiting potential investors, with a submission deadline of March 4, 2026, at 17:00, requiring a deposit of 80 million yuan [1] - This recruitment may lead to a change in company control, but the company emphasizes its operational independence from the controlling shareholder, stating that production and operations remain unaffected [1] Financial Performance - In the first three quarters of 2025, the company achieved a revenue of 2.033 billion yuan, a year-on-year decrease of 2.6%, while the net profit attributable to shareholders increased by 48.1% to 106 million yuan [2] - However, the net cash flow from operating activities decreased by 68.7% to 103 million yuan, indicating cash flow pressure [2] - The company's non-deductible net profit increased by 76.2%, reflecting an improvement in profitability [2] Company Status - The company announced in January 2025 its intention to use asset pledges to apply for loans, with the pledged asset's net value approximately 987 million yuan [3] - There are also pending lawsuits, including a lawsuit filed in December 2025 seeking to terminate a patent licensing agreement and recover deposits, which may introduce operational uncertainties [3]

Core Viewpoint - Beiyinmei Co., Ltd. is undergoing a pre-restructuring process due to significant debt issues faced by its controlling shareholder, Xiaobei Damei Holdings, which may lead to a change in control of the company [1][4][12]. Group 1: Debt and Restructuring - Xiaobei Damei Holdings has debts amounting to at least 2.1 billion yuan, with a high proportion of its shares pledged [1][3]. - The pre-restructuring plan was approved by the creditors' meeting, with significant support from both secured and unsecured creditors [2][3]. - The company is actively seeking restructuring investors with industrial synergy and financial strength to stabilize operations and optimize asset and debt structures [3][12]. Group 2: Company Background and Control - Xiaobei Damei Holdings, previously known as Beiyinmei Group, was established in July 2003 and is primarily controlled by its founder, Xie Hong, who holds 83.33% of the shares [5][6]. - The core asset of Xiaobei Damei is its 12.28% stake in Beiyinmei, with 98.85% of these shares pledged or frozen [6][9]. - The restructuring success is uncertain and may lead to a change in control, impacting Beiyinmei's stability and investor confidence [4][12]. Group 3: Market Context - The infant formula market is currently in a phase of stock competition, which poses challenges for attracting industrial investors to Xiaobei Damei's core assets [12]. - Beiyinmei has experienced fluctuating revenues and profits, with recent financial reports indicating a slight decline in revenue but an increase in net profit [11].

Group 1 - The company Beiningmei (002570.SZ) announced that as of February 11, 2026, it has repurchased a total of 22.55 million shares through a dedicated securities account via centralized bidding, accounting for 2.0881% of the company's total share capital [1] - The maximum transaction price for the repurchased shares was 7.21 yuan per share, while the minimum transaction price was 6.01 yuan per share [1] - The total amount spent on the share repurchase was 141 million yuan, excluding transaction fees [1]

证券代码：002570 证券简称：贝因美 公告编号：2026-015 贝因美股份有限公司 关于回购公司股份超过2%的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 贝因美股份有限公司（以下简称"公司"）于 2025 年 4 月 29 日召开的第九 届董事会第九次会议审议通过了《关于回购公司股份方案的议案》，公司拟以集 中竞价交易方式回购公司 A 股股票，用于公司未来实施的股权激励或员工持股 计划。本次回购金额不超过人民币 3 亿元（含），不低于人民币 1.5 亿元（含）， 回购价格不超过 9.06 元/股（含），实施期限为自董事会审议通过回购方案之日 起 12 个月内。具体内容详见公司于 2025 年 4 月 30 日披露于指定信息披露媒体 及巨潮资讯网（http://www.cninfo.com.cn）上的《关于回购公司股份方案暨取得 股票回购专项贷款承诺函的公告》（公告编号：2025-035）。 根据《深圳证券交易所上市公司自律监管指引第 9 号——回购股份》等相关 规定，上市公司在回购期间，回购股份占上市公司总股本的比例每增加百分之一 的，应当 ...